A Phase II Evaluation Of Pemetrexed (ALIMTA, LY231517, IND #40061) In the Treatment Of Recurrent Carcinoma Of The Cervix
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2014
At a glance
- Drugs Pemetrexed (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 06 Aug 2008 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 08 Feb 2008 Status changed from in progress to discontinued; according to clinicaltrials.gov.
- 06 Aug 2007 Status change from suspended to in progress.